Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability
Year: 2020
Type: article
Abstract: Demonstrate rapid initiation of co-formulated treatment during acute HIV infection (AHI) is feasible and efficacious.
DOI: 10.17615/2zer-k998
Authors: Kuruc, Jo Ann D., McGee, Kara S., Margolis, David M., Hicks, Charles B., Crooks, Amanda M., Gay, Cynthia L., Ferrari, Guido, McKellar, Mehri S., Willis, Sarah J., Cope, Anna B., Fiscus, Susan A., Eron, Joseph J., Sebastian, Joe
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4301481836
